<code id='026F484BE1'></code><style id='026F484BE1'></style>

<acronym id='026F484BE1'></acronym>

<center id='026F484BE1'><center id='026F484BE1'><tfoot id='026F484BE1'></tfoot></center><abbr id='026F484BE1'><dir id='026F484BE1'><tfoot id='026F484BE1'></tfoot><noframes id='026F484BE1'>

<optgroup id='026F484BE1'><strike id='026F484BE1'><sup id='026F484BE1'></sup></strike><code id='026F484BE1'></code></optgroup>

<b id='026F484BE1'><label id='026F484BE1'><select id='026F484BE1'><dt id='026F484BE1'><span id='026F484BE1'></span></dt></select></label></b><u id='026F484BE1'></u>

~~<i id='026F484BE1'><strike id='026F484BE1'><tt id='026F484BE1'><pre id='026F484BE1'></pre></tt></strike></i>~~

Home» knowledge» knowledge

knowledge

knowledge

author：knowledge 2025-09-28 08:16:53 Page View：242

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

advertisement

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ARCH Venture Partners is raising $3 billion for a life sciences fund
Next article： Anesthesiologist group: stop taking Ozempic before surgery

explore

Psychedelics group wrestles with new pharma identity

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

ARCH Venture Partners is raising $3 billion for a life sciences fund

ARCH Venture Partners is raising $3 billion for a life sciences fund

AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The

Medical records are filled with copy

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

ARCH Venture Partners is raising $3 billion for a life sciences fund

AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The

read more